USPTO serial 99030403
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Biocalth International Inc.
La Verne, CA, US
Biocalth International Inc.
La Verne, CA, US
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Ganoderma lucidum spore powder dietary supplements; Pine pollen dietary supplements; Fungicides, herbicides; Adult diapers; Alginate dietary supplements; Algicides; Alginates for pharmaceutical purposes; Amino acids for medical purposes; Genetic identity tests comprised of reagents for medical purposes; Spermicides; Otorhinolaryngological preparations; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Pharmaceutical preparations, namely, dantrolene sodium for injection; Dietary supplement for eliminating toxins from the intestinal tract; Nutritional supplement for eliminating toxins from the intestinal tract; Prenatal vitamins; Pharmaceutical products for the prevention and treatment of cancer; Bone paste for medical purposes; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Cartridges sold pre-filled with gases and gas mixtures for medical use; Saline solution for medical purposes; Dental tablets for disclosing plaque and tartar on the teeth; Dental sealants; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Dental compounds used in endodontic procedures; Contrast media for use with imaging medical equipment; Diuretic preparations; Imaging agents for magnetic resonance imaging (MRI); Meal replacement drink mixes adapted for medical use; Dietetic beverages adapted for medical use; Syrups for making meal replacement beverages adapted for medical use; Dietetic foods adapted for veterinary use; Medicated dog washes; Medicated animal washes; Antibiotic creams; Rectally administered agents for weight control and appetite suppression; Therapeutic agents for weight control and appetite suppression; Malted milk beverages for medical purposes; Plasters for medical purposes; Parasiticides; Demineralised water for medical purposes; Cough pastilles for medical use; Medicated dentifrices; Dietetic foods and beverages adapted for medical use; Infant formula; Reagent paper for veterinary purposes; Homogenised food adapted for medical purposes; Homogenized food adapted for medical purposes; Medicinal drinks; Antiparasitic preparations; Anaesthetics; Air purifying preparations; Adhesive tapes for medical purposes; Sanitary towels; Medicinal herbs; Medicinal tea; Bacterial poisons; Deodorizing sprays for toilets; Bandages, elastic, for dressings; Inhalants for the treatment of asthma; Inhalants for the treatment of respiratory conditions; Adhesive nipple patches for medical purposes; Cough treatment preparations; Nanosilver antimicrobial dressings for medical use; Carrying cases specially adapted for filled oxygen cylinders for medical purposes; Cells for medical purposes; Media for cell cultures for veterinary use; Media for cell cultures for veterinary purposes; Cell culture media for veterinary use; Cell culture media for veterinary purposes; Cell culture media for medical use; Preparations for destroying flies; Fly destroying preparations; Antibody reagents used for the detection of antigens in cells and tissue for medical purposes; Bone void fillers consisting primarily of biological materials and also incorporating synthetic materials; First aid dressings; Dressings for medical and veterinary purposes; Bacteriological preparations for medical or veterinary use; Bacteriological preparations for medical use; Bacteriological preparations for veterinary use; Bacterial preparations for medical and veterinary purposes; Bacterial preparations for medical or veterinary use; Bacterial preparations for medical or veterinary purposes; Biological preparations for use in cell cultures for medical purposes; Liquid formula milk for babies; Gases and gas mixtures for use in medical imaging; Isopropyl alcohol for medical use; Medicated oral care gels; Trypsins for medical purposes; Food for infants; First aid kits for pets; Pet first aid kits; Oxygen for therapeutic purposes | ACTIVE | Mar 1, 2026 |
| Date | Code | Event |
|---|---|---|
| Aug 25, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Aug 25, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Aug 25, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE |
| Jul 15, 2026 | IUAF | USE AMENDMENT FILED |
| Jul 15, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED |
| Jan 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION |
| Nov 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 5, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED |
| Nov 5, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Nov 5, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED |
| Nov 5, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN |
| Jul 22, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 22, 2025 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 15, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Feb 5, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Feb 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 5, 2025 | NWAP | NEW APPLICATION ENTERED |